Beyond Air Q3 FY2025 revenue $1.1M (+34% QoQ); cash burn $7.6M; CE Mark for LungFit PH in Europe

Beyond Air, Inc.

2025-Q3 EPS reported -$0.64 vs consensus -$0.87 ▲ beat (+26.6%)

Revenue $1.1M for Dec 31, 2024 quarter, up 34% from $0.8M in prior quarter and up from $0.4M YoY.
Cash, cash equivalents and marketable securities $10.9M; debt $11.8M; cash burn $7.6M in quarter.
Received CE Mark for LungFit PH in Europe; market authorization in Australia; initial shipments expected later 2025.
Six new U.S. hospital starts for LungFit PH in Q3; CE Mark triggers $1M milestone from Getz Healthcare due in Q4 FY2025.
NeuroNOS appointed Nobel laureate Prof. Roger D. Kornberg to Scientific Advisory Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.